+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID06901817

Phase II Study of Intraventricular Pemetrexed and Nivolumab for Treating Refractory Non-squamous Non-small Cell Lung Cancer with Leptomeningeal Metastases

Led by Shanghai Cancer Hospital, China · Updated on 2025-03-30

97

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of combining Pemetrexed and Nivolumab injected into the brain ventricles to treat refractory non-squamous non-small cell lung cancer that has spread to the membranes surrounding the brain and spinal cord leptomeningeal metastases. This Phase II study aims to determine if this treatment combination is safe and how well it controls the disease in patients who have already received prior treatments. Participants will receive intraventricular injections of 30 mg Pemetrexed and 40 mg Nivolumab through an implanted Ommaya reservoir every four weeks until their disease progresses. Before each treatment, a dose of dexamethasone is given intraventricularly to help manage inflammation. This treatment approach focuses on delivering drugs directly to the affected areas in the brain and spinal fluid. During the study, participants will be monitored for adverse events within 30 days and assessed for their disease response over one year. Researchers will evaluate the safety of the injections and measure how well the treatment controls the cancer. The study involves regular treatment visits spaced four weeks apart, and participants are observed until disease progression or other study endpoints. The trial is sponsored by Shanghai Cancer Hospital, China.

CONDITIONS

Brief Title

A Study of the Safety and Efficacy of Pemetrexed Combined with Nivolumab Via Intraventricular Injection for the Treatment of Refractory Non-squamous Non-small Cell Lung Cancer with Leptomeningeal Metastases

Research Team

M

Min Fan, M.D.

J

Jiayan Chen, M.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here